Evrópusambandið - íslenska - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod stutt og long-term - multiple sclerosis, relapsing-remitting; colitis, ulcerative - Ónæmisbælandi lyf - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

animedica gmbh* - chlortetracycline hydrochloride - húðúði, dreifa - 2,45 % w/w

Evrópusambandið - íslenska - EMA (European Medicines Agency)

ceva santé animale - óvirkt coxiella burnetii bóluefni, stofn nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

animedica gmbh* - cloprostenolum natríum - stungulyf, lausn - 75 míkróg/ml

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

animedica gmbh - menbutone - stungulyf, lausn - 100 mg/ml

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

animedica gmbh* - enrofloxacinum inn - tafla - 150 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

animedica gmbh* - enrofloxacinum inn - tafla - 50 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

animedica gmbh* - butorphanolum tartrat - stungulyf, lausn - 4 mg/ml

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

animedica gmbh* - benzylpenicillinprocainum - spenalyf, dreifa - 3 g

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

animedica gmbh* - butorphanolum tartrat - stungulyf, lausn - 10 mg/ml